The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized mice

Journal of Experimental Medicine

Volumn 208, Issue 7, 2011, Pages 1511-1522

  Tu, Wenwei ^a,b   Zheng, Jian ^a   Liu, Yinping ^a   Sia, Sin Fun ^a   Liu, Ming ^c   Qin, Gang ^a   Ng, Iris H Y ^a   Xiang, Zheng ^a   Lam, Kwok Tai ^a   Peiris, J S Malik ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOBISPHOSPHONATE PAMIDRONATE; PAMIDRONIC ACID; RAG2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOWL; GAMMA DELTA T LYMPHOCYTE; HOST; IN VITRO STUDY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYTOTOXICITY, IMMUNOLOGIC; DIPHOSPHONATES; HOST-PARASITE INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; LUNG; LYMPHOCYTE DEPLETION; MICE; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

EID: 79960360772     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20110226     Document Type: Article

References (68)

1. Agrati, C., T. Alonzi, R. De Santis, C. Castilletti, I. Abbate, M.R. Capobianchi, G. D'Offizi, F. Siepi, G.M. Fimia, M. Tripodi, and F. Poccia. 2006. Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication. Int. Immunol. 18:11-18.
2. Battistini, L., N. Caccamo, G. Borsellino, S. Meraviglia, D.F. Angelini, F. Dieli, M.T. Cencioni, and A. Salerno. 2005. Homing and memory patterns of human gammadelta T cells in physiopathological situations. Microbes Infect. 7:510-517.
3. Beck, B.H., H.G. Kim, H. Kim, S. Samuel, Z. Liu, R. Shrestha, H. Haines, K. Zinn, and R.D. Lopez. 2010. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer. Breast Cancer Res. Treat. 122:135-144.
4. Beetz, S., D. Wesch, L. Marischen, S. Welte, H.H. Oberg, and D. Kabelitz. 2008. Innate immune functions of human gammadelta T cells. Immunobiology. 213:173-182.
5. Beigel, J.H., J. Farrar, A.M. Han, F.G. Hayden, R. Hyer, M.D. de Jong, S. Lochindarat, T.K. Nguyen, T.H. Nguyen, T.H. Tran, et al; Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353:1374-1385.
6. Bonneville, M., and J.J. Fournié. 2005. Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites. Microbes Infect. 7:503-509.
7. Bonneville, M., and E. Scotet. 2006. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 18:539-546.
8. Bonneville, M., R.L. O'Brien, and W.K. Born. 2010. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10:467-478.
9. Born, W.K., C.L. Reardon, and R.L. O'Brien. 2006. The function of gammadelta T cells in innate immunity. Curr. Opin. Immunol. 18:31-38.
10. Born, W.K., N. Jin, M.K. Aydintug, J.M. Wands, J.D. French, C.L. Roark, and R.L. O'Brien. 2007. gammadelta T lymphocytes-selectable cells within the innate system? J. Clin. Immunol. 27:133-144.
11. Brandes, M., K. Willimann, and B. Moser. 2005. Professional antigenpresentation function by human gammadelta T Cells. Science. 309:264-268.
12. Brandes, M., K. Willimann, G. Bioley, N. Lévy, M. Eberl, M. Luo, R. Tampé, F. Lévy, P. Romero, and B. Moser. 2009. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc. Natl. Acad. Sci. USA. 106:2307-2312.
13. Bukowski, J.F., C.T. Morita, and M.B. Brenner. 1994. Recognition and destruction of virus-infected cells by human gamma delta CTL. J. Immunol. 153:5133-5140.
14. Caccamo, N., S. Meraviglia, F. Scarpa, C. La Mendola, D. Santini, C.T. Bonanno, G. Misiano, F. Dieli, and A. Salerno. 2008. Aminobisphosphonateactivated gammadelta T cells in immunotherapy of cancer: doubts no more. Expert Opin. Biol. Ther. 8:875-883.
15. Carding, S.R., and P.J. Egan. 2002. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2:336-345.
16. Chan, M.C., C.Y. Cheung, W.H. Chui, S.W. Tsao, J.M. Nicholls, Y.O. Chan, R.W. Chan, H.T. Long, L.L. Poon, Y. Guan, and J.S. Peiris. 2005. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6:135.
17. Cheung, C.Y., L.L. Poon, A.S. Lau, W. Luk, Y.L. Lau, K.F. Shortridge, S. Gordon, Y. Guan, and J.S. Peiris. 2002. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet. 360:1831-1837.
18. Das, H., L. Wang, A. Kamath, and J.F. Bukowski. 2001. Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates. Blood. 98:1616-1618.
19. Dawood, F.S., S. Jain, L. Finelli, M.W. Shaw, S. Lindstrom, R.J. Garten, L.V. Gubareva, X. Xu, C.B. Bridges, and T.M. Uyeki; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615.
20. Dharan, N.J., L.V. Gubareva, J.J. Meyer, M. Okomo-Adhiambo, R.C. McClinton, S.A. Marshall, K. St George, S. Epperson, L. Brammer, A.I. Klimov, et al; Oseltamivir-Resistance Working Group. 2009. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 301:1034-1041.
21. Dieli, F., N. Caccamo, and S. Meraviglia. 2008. Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and more. Curr. Opin. Investig. Drugs. 9:1089-1094.
22. Dybing, J.K., S. Schultz-Cherry, D.E. Swayne, D.L. Suarez, and M.L. Perdue. 2000. Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J. Virol. 74:1443-1450.
23. Eberl, M., and B. Moser. 2009. Monocytes and gammadelta T cells: close encounters in microbial infection. Trends Immunol. 30:562-568.
24. Feuerer, M., P. Beckhove, L. Bai, E.F. Solomayer, G. Bastert, I.J. Diel, C. Pedain, M. Oberniedermayr, V. Schirrmacher, and V. Umansky. 2001. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat. Med. 7:452-458.
25. Fraser, C., C.A. Donnelly, S. Cauchemez, W.P. Hanage, M.D. Van Kerkhove, T.D. Hollingsworth, J. Griffin, R.F. Baggaley, H.E. Jenkins, E.J. Lyons, et al; WHO Rapid Pandemic Assessment Collaboration. 2009. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 324:1557-1561.
26. Garten, R.J., C.T. Davis, C.A. Russell, B. Shu, S. Lindstrom, A. Balish, W.M. Sessions, X. Xu, E. Skepner, V. Deyde, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 325:197-201.
27. Guan, Y., L.L. Poon, C.Y. Cheung, T.M. Ellis, W. Lim, A.S. Lipatov, K.H. Chan, K.M. Sturm-Ramirez, C.L. Cheung, Y.H. Leung, et al. 2004. H5N1 influenza: a protean pandemic threat. Proc. Natl. Acad. Sci. USA. 101:8156-8161.
28. Hancock, K., V. Veguilla, X. Lu, W. Zhong, E.N. Butler, H. Sun, F. Liu, L. Dong, J.R. DeVos, P.M. Gargiullo, et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
29. Huang, D., C.Y. Chen, Z. Ali, L. Shao, L. Shen, H.A. Lockman, R.E. Barnewall, C. Sabourin, J. Eestep, A. Reichenberg, et al. 2009. Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions. Proc. Natl. Acad. Sci. USA. 106:7553-7558.
30. Jiang, Q., L. Zhang, R. Wang, J. Jeffrey, M.L. Washburn, D. Brouwer, S. Barbour, G.I. Kovalev, D. Unutmaz, and L. Su. 2008. FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo. Blood. 112:2858-2868.
31. Kabelitz, D., D. Wesch, E. Pitters, and M. Zöller. 2004. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo. J. Immunol. 173:6767-6776.
32. King, M.A. 2000. Detection of dead cells and measurement of cell killing by flow cytometry. J. Immunol. Methods. 243:155-166.
33. Konigshofer, Y., and Y.H. Chien. 2006. Gammadelta T cells - innate immune lymphocytes? Curr. Opin. Immunol. 18:527-533.
34. Kuang, D.M., Q. Zhao, C. Peng, J. Xu, J.P. Zhang, C. Wu, and L. Zheng. 2009. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206:1327-1337.
35. Kunzmann, V., E. Bauer, and M. Wilhelm. 1999. Gamma/delta T-cell stimulation by pamidronate. N. Engl. J. Med. 340:737-738.
36. Lackenby, A., C.I. Thompson, and J. Democratis. 2008. The potential impact of neuraminidase inhibitor resistant influenza. Curr. Opin. Infect. Dis. 21:626-638.
37. Layne, S.P., A.S. Monto, and J.K. Taubenberger. 2009. Pandemic influenza: an inconvenient mutation. Science. 323:1560-1561.
38. Mao, H., W. Tu, G. Qin, H.K. Law, S.F. Sia, P.L. Chan, Y. Liu, K.T. Lam, J. Zheng, M. Peiris, and Y.L. Lau. 2009. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J. Virol. 83:9215-9222.
39. Mao, H., W. Tu, Y. Liu, G. Qin, J. Zheng, P.L. Chan, K.T. Lam, J.S. Peiris, and Y.L. Lau. 2010. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J. Virol. 84:4148-4157.
40. Maniar, A., X. Zhang, W. Lin, B.R. Gastman, C.D. Pauza, S.E. Strome, and A.I. Chapoval. 2010. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood. 116:1726-1733.
41. Mattarollo, S.R., T. Kenna, M. Nieda, and A.J. Nicol. 2007. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer Immunol. Immunother. 56:1285-1297.
42. Medina, R.A., B. Manicassamy, S. Stertz, C.W. Seibert, R. Hai, R.B. Belshe, S.E. Frey, C.F. Basler, P. Palese, and A. Garcia-Sastre. 2010. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat. Commun. 1:1-6.
43. Moscona, A. 2009. Global transmission of oseltamivir-resistant influenza. N. Engl. J. Med. 360:953-956.
44. Ohashi, K., P.L. Marion, H. Nakai, L. Meuse, J.M. Cullen, B.B. Bordier, R. Schwall, H.B. Greenberg, J.S. Glenn, and M.A. Kay. 2000. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6:327-331.
45. Palese, P. 2004. Influenza: old and new threats. Nat. Med. 10:S82-S87.
46. Pearson, T., D.L. Greiner, and L.D. Shultz. 2008. Humanized SCID mouse models for biomedical research. Curr. Top. Microbiol. Immunol. 324:25-51.
47. Peiris, J.S., W.W. Tu, and H.L. Yen. 2009. A novel H1N1 virus causes the first pandemic of the 21st century. Eur. J. Immunol. 39:2946-2954.
48. Poccia, F., C. Agrati, F. Martini, M.R. Capobianchi, M. Wallace, and M. Malkovsky. 2005a. Antiviral reactivities of gammadelta T cells. Microbes Infect. 7:518-528.
49. Poccia, F., C. Agrati, F. Martini, G. Mejia, M. Wallace, and M. Malkovsky. 2005b. Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy. Immunol. Lett. 100:14-20.
50. Poccia, F., C. Agrati, C. Castilletti, L. Bordi, C. Gioia, D. Horejsh, G. Ippolito, P.K. Chan, D.S. Hui, J.J. Sung, et al. 2006. Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. J. Infect. Dis. 193:1244-1249.
51. Puan, K.J., C. Jin, H. Wang, G. Sarikonda, A.M. Raker, H.K. Lee, M.I. Samuelson, E. Märker-Hermann, L. Pasa-Tolic, E. Nieves, et al. 2007. Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells. Int. Immunol. 19:657-673.
52. Qin, G., H. Mao, J. Zheng, S.F. Sia, Y. Liu, P.L. Chan, K.T. Lam, J.S. Peiris, Y.L. Lau, and W. Tu. 2009. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J. Infect. Dis. 200:858-865.
53. Sciammas, R., and J.A. Bluestone. 1999. TCRgammadelta cells and viruses. Microbes Infect. 1:203-212.
54. Scotet, E., L.O. Martinez, E. Grant, R. Barbaras, P. Jenö, M. Guiraud, B. Monsarrat, X. Saulquin, S. Maillet, J.P. Estève, et al. 2005. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity. 22:71-80.
55. Seo, S.H., E. Hoffmann, and R.G. Webster. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8:950-954.
56. Shen, Y., D. Zhou, L. Qiu, X. Lai, M. Simon, L. Shen, Z. Kou, Q. Wang, L. Jiang, J. Estep, et al. 2002. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science. 295:2255-2258.
57. Sicard, H., S. Ingoure, B. Luciani, C. Serraz, J.J. Fournié, M. Bonneville, J. Tiollier, and F. Romagné. 2005. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 175:5471-5480.
58. Stoddart, C.A., T.J. Liegler, F. Mammano, V.D. Linquist-Stepps, M.S. Hayden, S.G. Deeks, R.M. Grant, F. Clavel, and J.M. McCune. 2001. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat. Med. 7:712-718.
59. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, J.C. Piffaretti, A. Lanzavecchia, and M.G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 304:104-107.
60. Tu, W., S. Chen, M. Sharp, C. Dekker, A.M. Manganello, E.C. Tongson, H.T. Maecker, T.H. Holmes, Z. Wang, G. Kemble, et al. 2004. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 172:3260-3267.
61. Tu, W., L. Potena, P. Stepick-Biek, L. Liu, K.Y. Dionis, H. Luikart, W.F. Fearon, T.H. Holmes, C. Chin, J.P. Cooke, et al. 2006. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation. 114:1608-1615.
62. Tu, W., H. Mao, J. Zheng, Y. Liu, S.S. Chiu, G. Qin, P.L. Chan, K.T. Lam, J. Guan, L. Zhang, et al. 2010. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 84:6527-6535.
63. Tumpey, T.M., C.F. Basler, P.V. Aguilar, H. Zeng, A. Solórzano, D.E. Swayne, N.J. Cox, J.M. Katz, J.K. Taubenberger, P. Palese, and A. García-Sastre. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 310:77-80.
64. Urban, E.M., A.I. Chapoval, and C.D. Pauza. 2010. Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells. Clin. Dev. Immunol. 2010:732893.
65. Wang, L., A. Kamath, H. Das, L. Li, and J.F. Bukowski. 2001. Antibacterial effect of human V gamma 2V delta 2 T cells in vivo. J. Clin. Invest. 108:1349-1357.
66. Zeine, R., R. Pon, U. Ladiwala, J.P. Antel, L.G. Filion, and M.S. Freedman. 1998. Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis. J. Neuroimmunol. 87:49-61.
67. Zheng, J., Y. Liu, G. Qin, P.L. Chan, H. Mao, K.T. Lam, D.B. Lewis, Y.L. Lau, and W. Tu. 2009. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J. Immunol. 183:3742-3750.
68. Zhou, J., H.K. Law, C.Y. Cheung, I.H. Ng, J.S. Peiris, and Y.L. Lau. 2006. Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages. J. Infect. Dis. 193:945-953.